I think the issues with overscreening are a really hard thing for most doctors to get, because they are extremely counterintuitive. @venkmurthy has some excellent tweetorials on issues similar to the (potential) overuse of CGM
-
-
If I had to summarize how I see the conflict between the "CGM camps", it's a philosophical disagreement: those who believe that until threshold of HbA1c of 6 is reached, no intervention is required. Versus those who believe HbA1c represents a continuum of risk.
-
That's certainly a question, but I'd say it's more about when you expect to see a benefit (particularly in terms of hard outcomes, like retinopathy) given that CGM can be quite expensive to use long-term
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.